Penumbra (PEN) Change in Account Payables (2014 - 2026)
Penumbra (PEN) reported Change in Account Payables of $9.0 million for Q1 2026, up 3672.11% year-over-year from $237691.8 in Q1 2025, and up 97.58% quarter-over-quarter from $4.5 million in Q4 2025.
Penumbra (PEN) Change in Account Payables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Change in Account Payables data on file, last reported at $9.0 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $9.0 million, up 3672.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 million (up 1053.73% YoY), and the FY2025 annual result was $3.1 million, down 26.49% from the prior year.
- Change in Account Payables advanced to $9.0 million in Q1 2026 per PEN's latest filing, from $4.5 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $9.0 million in Q1 2026 and troughed at -$3.2 million in Q2 2025.
- A 5-year average of $1.8 million and a median of $1.4 million in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables sank 1248.06% in 2025, then soared 3672.11% in 2026.
- A 5-year view of Change in Account Payables shows it stood at $295000.0 in 2022, then sank by 424.41% to -$957000.0 in 2023, then sank by 94.67% to -$1.9 million in 2024, then jumped by 343.59% to $4.5 million in 2025, then surged by 97.58% to $9.0 million in 2026.
- Business Quant data shows PEN's Change in Account Payables at $9.0 million in Q1 2026, $4.5 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 8.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.97 Mn |
| Mar 31, 2026 | 8.97 Mn |
| Dec 31, 2025 | 4.54 Mn |
| Dec 31, 2025 | 4.54 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Mar 31, 2025 | -251,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Dec 31, 2024 | -1.86 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Sep 30, 2024 | 543,000.00 |
| Sep 30, 2024 | 543,000.00 |
| Jun 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 283,000.00 |
| Mar 31, 2024 | 5.21 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | -957,000.00 |
| Dec 31, 2023 | -957,000.00 |